Evidence map›Paper›PMID 42584750›Full record

ArticleAnnals of surgical oncology2026

Competing-Risk Regression Analysis of Cancer-Specific and Other-Cause Mortality after Partial versus Radical Nephrectomy in T3aN0M0 Renal Cell Carcinoma.

Xuanji Li, Zhiliang Jiang, Huan Ren, Yaxiong Tang, Xianyanling Yi, Zeyu Han, Jianzhong Ai

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xuanji Li *Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Zhiliang Jiang *Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Huan Ren *Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Yaxiong TangDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Xianyanling YiDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Zeyu HanDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Jianzhong AiDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. jianzhong.ai@scu.edu.cn.

Funding

the National Key R&D Program of China 2023YFC3403200the National Natural Science Foundation of China 82472774
6 · The paper itself

Abstract

backgroundThe optimal surgical management for T3aN0M0 renal cell carcinoma (RCC) remains debated. Radical nephrectomy (RN) is generally considered the standard treatment, whereas partial nephrectomy (PN) may preserve renal function, but the comparative long-term survival outcomes between these approaches remain unclear. PATIENTS AND

methodsUsing the Surveillance, Epidemiology, and End Results (SEER) database, we compared cancer-specific mortality (CSM) and other-cause mortality (OCM) between PN and RN in patients with T3aN0M0 RCC. One-to-one propensity score matching (PSM) was performed. Cumulative incidence curves were generated, and univariable and multivariable Fine-Gray competing-risk regression (CRR) were applied to evaluate CSM and OCM. Subgroup analyses were performed by tumor size and age.

resultsA total of 17,032 patients were included, of whom 2805 underwent PN and 14,227 underwent RN. After PSM, multivariable CRR analysis showed that PN was not associated with increased CSM compared with RN in the overall matched cohort (subdistribution hazard ratio (sHR) 0.77; 95% confidence interval (CI) 0.65-0.90; p < 0.001), with similar findings across subgroup analyses. PN was associated with lower OCM in patients with tumors measuring 1-40 mm (sHR 0.84; 95% CI 0.71-0.99; p = 0.036), whereas no significant OCM difference was observed in other subgroups.

conclusionsPN was not associated with a higher hazard of CSM or OCM than RN in this matched cohort. Our findings should be interpreted cautiously given the inherent limitations of the retrospective study design. PN may be considered in carefully selected patients with smaller tumors when complete resection is feasible without compromising oncologic safety.

Identifiers

PMID42584750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.